Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

22.13 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 22.13
Bid (Size) 17.40 (3)
Ask (Size) 30.80 (2)
Prev. Close 22.13
Today's Range 22.13 - 22.13
52wk Range 4.250 - 25.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2023
 
Via Benzinga
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on... 
Via Benzinga

Performance

YTD
+100.73%
+100.73%
1 Month
+21.73%
+21.73%
3 Month
+123.54%
+123.54%
6 Month
+203.15%
+203.15%
1 Year
+80.65%
+80.65%

More News

Read More
Where MoonLake Stands With Analysts
Via Benzinga
10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
Via Benzinga
FDA Clears MoonLake's Nanobody Study For Arthritis Patients
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
Via Benzinga
10 Short Squeeze Candidates: China Jo-Jo Drugstores, Expion360, MoonLake, Silvergate And More
Via Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
Via Benzinga
Top 5 Health Care Stocks That May Collapse In February
Via Benzinga
Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week
Via Benzinga
Bitcoin Holder MicroStrategy, SurgePays And 3 Other Short Squeeze Stocks That Could Soar This Week
Via Benzinga
PaxMedica, SurgePays, Opal Fuels And More Short Squeeze Candidates That Could Soar This Week
Via Benzinga
Getty Images, MoonLake And 3 Other Short Squeeze Candidates That May Soar This Week
Via Benzinga
HireRight Holdings, Canoo, VEON And Other Big Gainers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
Via Benzinga
Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Via Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Via Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Via Benzinga
This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.